Literature DB >> 15503105

Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections.

Carsten Konrad1, Georg A Müller, Claus Langer, Gregor Kuhlenbäumer, Klaus Berger, Darius G Nabavi, Rainer Dziewas, Florian Stögbauer, Erich B Ringelstein, Ralf Junker.   

Abstract

Mild hyperhomocysteinemia is a probable risk factor for atherosclerotic diseases and stroke. Recently, associations of elevated plasma homocysteine concentrations in the acute phase and of MTHFR 677 TT genotype with spontaneous cervical artery dissections (sCAD) have been reported. The purpose of this study was to test this hypothesis in the currently largest sample of patients with sCAD, taking into account known factors influencing plasma homocysteine levels. Ninety-five patients with past sCAD were compared with 95 age- and sex-matched healthy individuals. Homocysteine, vitamin B6, B12, folate, and polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T), cystathionine beta-synthase (CBS 844ins68bp) and methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase (MTHFD1 G1958A) were assessed and any associations were analysed using multivariate statistics. The occurrence of sCAD was associated with elevated homocysteine levels with an odds ratio of 1.327 per 20 % percentile. Homocysteine levels were influenced by gender, smoking status, occurrence of hypertension, vitamin B12 and folate levels, and by the MTHFR TT genotype. MTHFR, CBS 844ins68bp, and MTHFD1 G1958A genotype were not independently associated with the occurrence of sCAD. These data suggest that elevated homocysteine is associated with the occurrence of sCAD. The MTHFR C677T polymorphism is associated with the homocysteine level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503105     DOI: 10.1007/s00415-004-0523-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

Review 1.  Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.

Authors:  Earl S Ford; S Jay Smith; Donna F Stroup; Karen K Steinberg; Patricia W Mueller; Stephen B Thacker
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

2.  Lifestyle factors and plasma homocysteine concentrations in a general population sample.

Authors:  A de Bree ; W M Verschuren; H J Blom; D Kromhout
Journal:  Am J Epidemiol       Date:  2001-07-15       Impact factor: 4.897

3.  Changes in plasma homocyst(e)ine in the acute phase after stroke.

Authors:  Virginia J Howard; Elizabeth G Sides; George C Newman; Stanley N Cohen; George Howard; M Rene Malinow; James F Toole
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

4.  Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).

Authors:  Lise Lotte N Husemoen; Troels F Thomsen; Mogens Fenger; Henrik L Jørgensen; Torben Jørgensen
Journal:  Genet Epidemiol       Date:  2003-05       Impact factor: 2.135

5.  Genetic defects as important factors for moderate hyperhomocysteinemia.

Authors:  J Geisel; I Zimbelmann; H Schorr; J P Knapp; M Bodis; U Hübner; W Herrmann
Journal:  Clin Chem Lab Med       Date:  2001-08       Impact factor: 3.694

6.  Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia.

Authors:  R de Franchis; I Fermo; G Mazzola; G Sebastio; G Di Minno; A Coppola; G Andria; A D'Angelo
Journal:  Thromb Haemost       Date:  2000-10       Impact factor: 5.249

Review 7.  Ischemic stroke in patients under age 45.

Authors:  J Bogousslavsky; P Pierre
Journal:  Neurol Clin       Date:  1992-02       Impact factor: 3.806

8.  Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

Authors:  J W Eikelboom; G J Hankey; S S Anand; E Lofthouse; N Staples; R I Baker
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

9.  Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.

Authors:  Alessandro Pezzini; Elisabetta Del Zotto; Silvana Archetti; Riccardo Negrini; Paolo Bani; Alberto Albertini; Mario Grassi; Deodato Assanelli; Roberto Gasparotti; Luigi Amedeo Vignolo; Mauro Magoni; Alessandro Padovani
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

10.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

Authors:  G Assmann; H Schulte
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

View more
  14 in total

1.  A narrative review of pathophysiological mechanisms associated with cervical artery dissection.

Authors:  Michael Haneline; Gary N Lewkovich
Journal:  J Can Chiropr Assoc       Date:  2007

2.  Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study.

Authors:  A Pezzini; V Caso; C Zanferrari; E Del Zotto; M Paciaroni; C Bertolino; M Grassi; G Agnelli; A Padovani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 3.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.

Authors:  Saranya Rajendran; Xinggui Shen; John Glawe; Gopi K Kolluru; Christopher G Kevil
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

4.  TGFBR2 mutation and MTHFR-C677T polymorphism in a Mexican mestizo population with cervico-cerebral artery dissection.

Authors:  Angélica Ruiz-Franco; Miguel A Barboza; Aurelio Jara-Prado; Samuel Canizales-Quinteros; Paola Leon-Mimila; Nayelli Arguelles-Morales; Juan-Camilo Vargas-González; Alejandro Quiroz-Compean; Antonio Arauz
Journal:  J Neurol       Date:  2016-03-26       Impact factor: 4.849

5.  MTHFR 677TT genotype increases the risk for cervical artery dissections.

Authors:  M Kloss; T Wiest; S Hyrenbach; I Werner; M-L Arnold; C Lichy; C Grond-Ginsbach
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08       Impact factor: 10.154

6.  Maternal and infant gene-folate interactions and the risk of neural tube defects.

Authors:  Analee J Etheredge; Richard H Finnell; Suzan L Carmichael; Edward J Lammer; Huiping Zhu; Laura E Mitchell; Gary M Shaw
Journal:  Am J Med Genet A       Date:  2012-08-17       Impact factor: 2.802

Review 7.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview.

Authors:  Anna E Beaudin; Patrick J Stover
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

8.  Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele.

Authors:  Maitreyi Mazumdar; Linda Valeri; Ema G Rodrigues; Md Omar Sharif Ibne Hasan; Rezina Hamid; Ligi Paul; Jacob Selhub; Fareesa Silva; Md Golam Mostofa; Quazi Quamruzzaman; Mahmuder Rahman; David C Christiani
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-08-06

9.  The etiology of cervical artery dissection.

Authors:  Michael T Haneline; Anthony L Rosner
Journal:  J Chiropr Med       Date:  2007-09

10.  Investigation of homocysteine-pathway-related variants in essential hypertension.

Authors:  Javed Y Fowdar; Marta V Lason; Attila L Szvetko; Rodney A Lea; Lyn R Griffiths
Journal:  Int J Hypertens       Date:  2012-10-23       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.